Acute Lymphoblastic Leukemia, Pediatric Not Yet Recruiting Phase 2 / 3 Trials for Mercaptopurine (DB01033)

Also known as: Pediatric Acute Lymphoblastic Leukemia / Acute Lymphoblastic Leukemia in Pediatric / Pediatric Patients With Acute Lymphoblastic Leukemia / Leukemia, Lymphoblastic, Acute, Pediatric

IndicationStatusPhase
DBCOND0081765 (Acute Lymphoblastic Leukemia, Pediatric)Not Yet Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04228393The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in ChinaTreatment